Medical Oncology

Prof. Dr. Sezer Sağlam

Doctor and researcher Gayrettepe Florence Nightingale Hastanesi İstanbul

Is this your profile? Claim it and verify your details.

Claim profile

CV

Education and experience

From source

Education

  • 2005İstanbul Üniversitesi Onkoloji Enstitüsü, Medikal Onkoloji Uzmanlık Eğitimiflorence.com.tr
  • 1996-1997Cerrahpaşa Tıp Fakültesi, Hemodiyaliz Eğitimiflorence.com.tr
  • 1991-1996Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Uzmanlık Eğitimiflorence.com.tr
  • 1991Ege Üniversitesi, Tıp Eğitimiflorence.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologyflorence.com.trFrom source
  • Department name at the sourceMedikal Onkolojiflorence.com.trFrom source
  • InstitutionGayrettepe Florence Nightingale Hastanesiflorence.com.trFrom source
  • Publications33 publicationsflorence.com.tr profile pageFrom source
  • Last synchronised7 November 2026 07:19https://www.florence.com.tr/doktorlar/prof-dr-sezer-saglamflorence.com.tr

Scientific work

Publications

33 publications
  1. Topuz E, Eralp Y, Saglam S, Saip P, Aydiner A, Berkman S, Yavuz E. "Efficacy of intraperitoneal cisplatin as consolidation therapy in patients with pathologic complete remission following front-line therapy for epithelial ovarian cancer. Consolidative intraperitoneal cisplatin in ovarian cancer."Gynecol Oncol. 92(1): 147–5, 2004.

    Source: florence.com.tr profile page

  2. Balci NC, Akun E, Erturk M, Saglam S, Inan N, Balci Y. "Renal-related perinephric fluid collections: MRI findings." Magn Reson Imaging. 23(5): 679–84, 2005.

    Source: florence.com.tr profile page

  3. Basaran M, Bavbek ES, Saglam S, Eralp L, Sakar B, Atalar AC, Bilgic B, Ozger H, Onat H. "A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas." Oncology. 72(3–4): 255–60, 2007.

    Source: florence.com.tr profile page

  4. Sakar B, Gumus M, Basaran M, Argon A, Ustuner Z, Ustaoglu MA, Saglam S, Guney N, Tenekeci AN, Aykan NF. "XELOX followed by XELIRI or the reverse sequence in advanced colorectal cancer." Oncology. 73(5–6): 298–304, 2007.

    Source: florence.com.tr profile page

  5. Topuz E, Derin D, Can G, Kürklü E, Cinar S, Aykan F, Cevikbaş A, Dişçi R, Durna Z, Sakar B, Saglam S, Tanyeri H, Deniz G, Gürer U, Taş F, Guney N, Aydiner A. "Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer." Invest New Drugs. 26(6): 567–72, 2008.

    Source: florence.com.tr profile page

  6. Balci NC, Befeler AS, Bieneman BK, Fattahi R, Saglam S, Havlioglu N. "Fat containing HCC: findings on CT and MRI including serial contrast-enhanced imaging." Acad Radiol. 16(8): 963–8, 2009.

    Source: florence.com.tr profile page

  7. Balci NC, Perman WH, Saglam S, Akisik F, Fattahi R, Bilgin M. "Diffusion-weighted magnetic resonance imaging of the pancreas." Top Magn Reson Imaging. 20(1): 43–7, 2009.

    Source: florence.com.tr profile page

  8. Saglam S, Suzme R, Gurdol F. "Serum tumor necrosis factor-alpha and interleukin-2 concentrations in newly diagnosed ERBB2 (HER2/neu) positive breast cancer patients." Int J Biol Markers. 24(3): 142–6, 2009.

    Source: florence.com.tr profile page

  9. Saglam S,Aykan NF,Şakar B et al. A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma. Journal of Gastrointestinal Oncology.2; 219-26, 2011

    Source: florence.com.tr profile page

  10. Effects of surgical laparoscopic experience on the short-term postoperative outcome of rectal cancer: results of a high volume single center institution.Balik E, Asoglu O, Saglam S, Yamaner S, Akyuz A, Buyukuncu Y, Gulluoglu M, Bulut T, Bugra D. Surg Laparosc Endosc Percutan Tech. 2010;20:93-9.

    Source: florence.com.tr profile page

View all 33 publications